Haemophilia B Clinical Trials

48 clinical trials for Haemophilia B across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors — RECRUITING
• A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN — RECRUITING
• Adverse Event Data Collection From External Registries on Nonacog Beta Pegol — RECRUITING
• Post-marketing Surveillance (Use Result Surveillance) With Refixia® — COMPLETED
• A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B — COMPLETED · PHASE3
• Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B — COMPLETED · PHASE3
• Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. — COMPLETED · PHASE3
• A Phase I/IIb extension study assessing the long-term safety and efficacy of an adeno-associated viral vector containing a codon-optimized human factor IX gene (AAV5-hFIX) previously administered to adult patients with severe or moderately severe haemophilia B during the CT-AMT-060-01 Phase I/II study. — OTHER · PHASE2
• Phase III, open-label, single-dose, multi-center multinational trial investigating a serotype 5 adeno-associated viral vector containing the Padua variant of a codon-optimized human factor IX gene (AAV5-hFIXco-Padua, AMT-061) administered to adult subjects with severe or moderately severe hemophilia B — OTHER · PHASE3
• Observatory of Patients With Haemophilia B Treated by IdElvion® — ACTIVE_NOT_RECRUITING
• A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B — COMPLETED
• A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France — COMPLETED
• Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B — COMPLETED
• A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B — COMPLETED · PHASE1
• A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) — COMPLETED
• A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia — COMPLETED
• Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B — COMPLETED · PHASE1
• Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 — COMPLETED · PHASE3
• A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery. — COMPLETED · PHASE3
• An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery — COMPLETED · PHASE3
• An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients — COMPLETED · PHASE3
• Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B — COMPLETED · PHASE3
• Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients — COMPLETED · PHASE3
• Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds — COMPLETED · PHASE2
• Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects — COMPLETED · PHASE1
• Survey Evaluating the Psychosocial Effects of Living With Haemophilia — COMPLETED
• Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B — COMPLETED · PHASE1
• Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries — COMPLETED
• Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia — COMPLETED
• Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State — COMPLETED · PHASE1
• Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database — COMPLETED
• Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B — COMPLETED · PHASE1
• A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers — COMPLETED · PHASE1
• Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients — COMPLETED · PHASE1
• Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State — COMPLETED · PHASE1
• A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care — COMPLETED
• Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S) — COMPLETED
• Project to Update the Study of Congenital Haemophilia in Spain — COMPLETED
• Thrombin Generation Numerical Models Validation in Haemophilic Case — COMPLETED
• To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives — COMPLETED
• Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B — COMPLETED
• A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors — COMPLETED · PHASE1
• Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors — COMPLETED
• A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B — COMPLETED · PHASE3
• A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years — COMPLETED · PHASE3
• Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects — COMPLETED · PHASE1
• Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy — COMPLETED · PHASE4
• Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects — WITHDRAWN · PHASE1

Refine this search